{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T17:58:39Z","timestamp":1784138319357,"version":"3.55.0"},"reference-count":51,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"unspecified","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Fogarty International Center of the National Institutes of Health","award":["D43 TW010543"],"award-info":[{"award-number":["D43 TW010543"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,7,15]]},"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sickle cell disease (SCD) is associated with significant mortality and morbidity, especially in low- and middle-income countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We determined the indications for hospitalisation and predictors of 30-day re-admission among patients with SCD in Northern and Central Uganda.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective chart review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Mulago National Referral Hospital in Kampala, St. Mary\u2019s Hospital Lacor in Gulu and Gulu Regional Referral Hospital in Gulu, Uganda.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Patients with confirmed SCD admitted between January 2020 and January 2025 were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes<\/jats:title>\n                    <jats:p>Primary outcome: indication for hospitalisation. Secondary outcomes: rate and predictors of 30-day hospital re-admission. Socio-demographic, clinical history and hospitalisation data were extracted using a pretested data extraction tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We enrolled 505 patients, accounting for 714 hospital admissions, with a mean age of 8.1\u00b16.2 years. Most participants (n=489, 96.8%) had less than four admissions per year, with a median of 1 admission (IQR: 0\u20132). The most common indications for hospitalisation were infection (n=375, 52.5%), painful crisis (n=366, 51.3%) and anaemia (n=186, 26.1%). Malaria was the most prevalent infection (n=244, 65%). The median length of hospital stay was 4\u2009days (IQR: 3\u20136), with a 30-day re-admission rate of 6.9% (n=49). Admission with painful crisis (adjusted OR (AOR): 0.45, 95%\u2009CI: 0.23 to 0.89, p=0.021), receiving a blood product (AOR: 0.32, 95%\u2009CI: 0.16 to 0.66, p=0.002) and having four or more admissions per year (AOR: 0.84, 95%\u2009CI: 0.04 to 0.17, p&lt;0.001) were inversely associated with re-admission within 30 days of last admission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Infections, especially malaria, and painful crises were the leading causes of hospitalisation among Ugandan patients with SCD. Frequent admissions, painful crises and blood transfusions were associated with lower 30-day re-admission risk. There is an urgent need to strengthen malaria prevention strategies and optimise access to disease-modifying therapy, such as hydroxyurea, to improve patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-104303","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T10:25:24Z","timestamp":1754648724000},"page":"e104303","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Indications for hospitalisation and predictors of 30-day re-admission of patients with sickle cell disease in Uganda: a retrospective study"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8837-1954","authenticated-orcid":false,"given":"Winnie","family":"Kibone","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology and Immunology, Gulu University, Gulu, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad","family":"Muzoora","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Mbarara University of Science and Technology, Mbarara, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4515-8517","authenticated-orcid":false,"given":"Felix","family":"Bongomin","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Immunology, Gulu University, Gulu, Uganda"},{"name":"Department of Internal Medicine, Gulu Regional Referral Hospital, Gulu, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret Amelia","family":"Namiiro","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Child health, Makerere University, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Ssenkungu","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Child health, Makerere University, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Ochola","sequence":"additional","affiliation":[{"name":"Department of HIV, Lacor Hospital, Gulu, Northern Region, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Kasirye","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Child health, Makerere University, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4700-1495","authenticated-orcid":false,"given":"Davidson H","family":"Hamer","sequence":"additional","affiliation":[{"name":"Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA"},{"name":"Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"2025123106454429000_15.8.e104303.1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(23)00118-7"},{"key":"2025123106454429000_15.8.e104303.2","unstructured":"Africa RCf . Sickle-Cell Disease in the African Region: Current Situation and the Way Forward Report of the Regional Director. WHO. Regional Office for Africa, 2006."},{"key":"2025123106454429000_15.8.e104303.3","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.06.036673"},{"key":"2025123106454429000_15.8.e104303.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61229-X"},{"key":"2025123106454429000_15.8.e104303.5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001484","article-title":"Global burden of sickle cell anaemia in children under five, 2010-2050: modelling based on demographics, excess mortality, and interventions","volume":"10","author":"Piel","year":"2013","journal-title":"PLoS Med"},{"key":"2025123106454429000_15.8.e104303.6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/tmi.13506","article-title":"Trends in sickle cell trait and disease screening in the Republic of Uganda, 2014-2019","volume":"26","author":"Hernandez","year":"2021","journal-title":"Trop Med Int Health"},{"key":"2025123106454429000_15.8.e104303.7","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1016\/S2214-109X(15)00288-0","article-title":"Burden of sickle cell trait and disease in the Uganda Sickle Surveillance Study (US3): a cross-sectional study","volume":"4","author":"Ndeezi","year":"2016","journal-title":"Lancet Glob Health"},{"key":"2025123106454429000_15.8.e104303.8","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-021-03074-z","article-title":"Vaso-occlusive crisis in sickle cell disease: a vicious cycle of secondary events","volume":"19","author":"Jang","year":"2021","journal-title":"J Transl Med"},{"key":"2025123106454429000_15.8.e104303.9","first-page":"546","article-title":"Infections in sickle cell disease","volume":"110","author":"Scourfield","year":"2025","journal-title":"Haematologica"},{"key":"2025123106454429000_15.8.e104303.10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002120","article-title":"Is Sickle Cell Anemia a Neglected Tropical Disease?","volume":"7","author":"Ware","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"2025123106454429000_15.8.e104303.11","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.028167"},{"key":"2025123106454429000_15.8.e104303.12","unstructured":"Hoffman R , Benz E . Haematology: basic principles and practice. Philadelphia: Elsevier, 2013."},{"key":"2025123106454429000_15.8.e104303.13","doi-asserted-by":"crossref","unstructured":"Hebbel RP , Vercellotti GM , Nath K . A systems biology consideration of the vasculopathy of sickle cell anemia: the need for multi-modality chemo-prophyla id=\"70b02cc9-8528-4845-b4b2-3e85df56dd88\">Cardiovasc Hematol Disord Drug Targets 2009;9:271\u201392. doi:10.2174\/1871529x10909040271","DOI":"10.2174\/1871529X10909040271"},{"key":"2025123106454429000_15.8.e104303.14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/ijlh.13023","article-title":"Sickle cell disease: Reducing the global disease burden","volume":"41 Suppl 1","author":"Mburu","year":"2019","journal-title":"Int J Lab Hematol"},{"key":"2025123106454429000_15.8.e104303.15","article-title":"Hospitalization Events Among Adolescents and Adults With Sickle Cell Disease in a Tertiary Care Center in Central India","volume":"16","author":"Wasnik","year":"2024","journal-title":"Cureus"},{"key":"2025123106454429000_15.8.e104303.16","article-title":"Reasons for Hospitalization of Sickle Cell Disease Patients in the Eastern Province of Saudi Arabia: A Single-Center Study","volume":"13","author":"Zakaria","year":"2021","journal-title":"Cureus"},{"key":"2025123106454429000_15.8.e104303.17","first-page":"34","article-title":"Morbidity and mortality pattern in hospitalized children with sickle cell disorders at the University College Hospital, Ibadan, Nigeria","volume":"40","author":"Brown","year":"2013","journal-title":"Nig J Paed"},{"key":"2025123106454429000_15.8.e104303.18","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2147\/JBM.S318824","article-title":"Analysis of Causes of Hospitalization Among Children with Sickle Cell Disease in a Group of Private Hospitals in Jeddah, Saudi Arabia","volume":"12","author":"Abd El-Ghany","year":"2021","journal-title":"J Blood Med"},{"key":"2025123106454429000_15.8.e104303.19","doi-asserted-by":"crossref","DOI":"10.1186\/s12878-018-0122-3","article-title":"The clinical presentation, utilization, and outcome of individuals with sickle cell anaemia presenting to urban emergency department of a tertiary hospital in Tanzania","volume":"18","author":"Sawe","year":"2018","journal-title":"BMC Hematol"},{"key":"2025123106454429000_15.8.e104303.20","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2023-187021","article-title":"Analyzing Treatment Patterns and Clinical Outcomes within the First 24 Hours of Hospitalization in Patients with Sickle Cell Disease and Infection: Evidence from a Retrospective Cohort Study","volume":"142","author":"Adams-Mitchell","year":"2023","journal-title":"Blood"},{"key":"2025123106454429000_15.8.e104303.21","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023021575"},{"key":"2025123106454429000_15.8.e104303.22","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1016\/S2214-109X(15)00298-3","article-title":"Is integrating sickle cell disease and HIV screening logical?","volume":"4","author":"Obaro","year":"2016","journal-title":"Lancet Glob Health"},{"key":"2025123106454429000_15.8.e104303.23","unstructured":"Kish L . Survey sampling. New York: John Wiley and Sons, Inc, 1965."},{"key":"2025123106454429000_15.8.e104303.24","unstructured":"Uganda Ministry of Health . Uganda clinical guidelines 2023: national guidelines for management of common health conditions. 2023."},{"key":"2025123106454429000_15.8.e104303.25","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21854"},{"key":"2025123106454429000_15.8.e104303.26","doi-asserted-by":"crossref","unstructured":"Kilungu A , Winchislaus E , Alberto G , et al . Outcomes and complications of sickle cell disease among hospitalized paediatric patients; a retrospective study in a tertiary hospital, tanzania. Hematology [Preprint]. doi:10.1101\/2025.03.18.25324182","DOI":"10.1101\/2025.03.18.25324182"},{"key":"2025123106454429000_15.8.e104303.27","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.18203\/2349-3291.ijcp20242727","article-title":"Pattern of admission and outcome at a newly established sickle cell center in Nigeria","volume":"11","author":"Ighosewe","year":"2024","journal-title":"Int J Contemp Pediatr"},{"key":"2025123106454429000_15.8.e104303.28","unstructured":"Ogol Japheth O . Ayodo George Hospitalization Events Among Sickle Cell Anemia Patients at Homabay County Referral Hospital, Western Kenya. Journal of Health, Medicine and Nursing 2018."},{"key":"2025123106454429000_15.8.e104303.29","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/195469","article-title":"Hospitalization Events among Children and Adolescents with Sickle Cell Disease in Basra, Iraq","volume":"2015","author":"Salman","year":"2015","journal-title":"Anemia"},{"key":"2025123106454429000_15.8.e104303.30","doi-asserted-by":"crossref","DOI":"10.1177\/2333794X221141356","article-title":"Acute Complications of Sickle Cell Disease in Children Under 5\u2009Years at a Level II Hospital","volume":"9","author":"Lage","year":"2022","journal-title":"Glob Pediatr Health"},{"key":"2025123106454429000_15.8.e104303.31","unstructured":"Fingar KR , Owens PL , Reid LD , et al . Characteristics of Inpatient Hospital Stays Involving Sickle Cell Disease, 2000\u20132016. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD): Agency for Healthcare Research and Quality (US), 2006."},{"key":"2025123106454429000_15.8.e104303.32","unstructured":"World malaria report 2023. Geneva World Health Organization; 2023."},{"key":"2025123106454429000_15.8.e104303.33","first-page":"2","article-title":"Trends and distribution of severe malaria cases, Uganda, 2017\u20132021: analysis of health management information system data","volume":"8","author":"Zalwango","year":"2023","journal-title":"Uganda National Institute of Public Health Q Epidemiol Bull"},{"key":"2025123106454429000_15.8.e104303.34","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-8-237","article-title":"Presumptive treatment with sulphadoxine-pyrimethamine versus weekly chloroquine for malaria prophylaxis in children with sickle cell anaemia in Uganda: a randomized controlled trial","volume":"8","author":"Nakibuuka","year":"2009","journal-title":"Malar J"},{"key":"2025123106454429000_15.8.e104303.35","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-018-3556-0","article-title":"Safety and effectiveness of antimalarial therapy in sickle cell disease: a systematic review and network meta-analysis","volume":"18","author":"Frimpong","year":"2018","journal-title":"BMC Infect Dis"},{"key":"2025123106454429000_15.8.e104303.36","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-265249"},{"key":"2025123106454429000_15.8.e104303.37","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.amjmed.2016.12.010","article-title":"Risk Factors for 30-Day Readmission in Adults with Sickle Cell Disease","volume":"130","author":"Brodsky","year":"2017","journal-title":"Am J Med"},{"key":"2025123106454429000_15.8.e104303.38","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.2147\/IJGM.S461778","article-title":"Predictive Factors for 30-Day Readmission and Increased Healthcare Utilization in Sickle Cell Disease Patients: A Single-Center Comparative Retrospective Study","volume":"17","author":"Alshabanat","year":"2024","journal-title":"Int J Gen Med"},{"key":"2025123106454429000_15.8.e104303.39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-58934-3","article-title":"Epidemiology and Predictors of all-cause 30-Day readmission in patients with sickle cell crisis","volume":"10","author":"Kumar","year":"2020","journal-title":"Sci Rep"},{"key":"2025123106454429000_15.8.e104303.40","doi-asserted-by":"crossref","DOI":"10.1155\/anem\/7143716","article-title":"Prevalence and Predictive Factors of Sickle Cell Emergencies Readmission in the Clinical Hematology Department of Dakar, Senegal","volume":"2024","author":"Diallo","year":"2024","journal-title":"Anemia"},{"key":"2025123106454429000_15.8.e104303.41","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1111\/trf.13155","article-title":"Blood transfusion and 30-day readmission rate in adult patients hospitalized with sickle cell disease crisis","volume":"55","author":"Nouraie","year":"2015","journal-title":"Transfusion"},{"key":"2025123106454429000_15.8.e104303.42","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.23221"},{"key":"2025123106454429000_15.8.e104303.43","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001143"},{"key":"2025123106454429000_15.8.e104303.44","article-title":"Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews","volume":"8","author":"Fortin","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2025123106454429000_15.8.e104303.45","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/vox.13757","article-title":"Quality of life in people with sickle cell disease treated with automated red blood cell exchange","volume":"120","author":"Dierick","year":"2025","journal-title":"Vox Sang"},{"key":"2025123106454429000_15.8.e104303.46","doi-asserted-by":"crossref","unstructured":"Zouki T , Haroutunian A , Malcolm T , et al . Pain management for the sickle cell patient. In: Shallik NA , ed. Pain Management in Special Circumstances. Rijeka: IntechOpen, 2018.","DOI":"10.5772\/intechopen.79495"},{"key":"2025123106454429000_15.8.e104303.47","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/jhm.850","article-title":"Prediction of onset and course of high hospital utilization in sickle cell disease","volume":"6","author":"Carroll","year":"2011","journal-title":"J Hosp Med"},{"key":"2025123106454429000_15.8.e104303.48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247324","article-title":"Characteristics of sickle cell patients with frequent emergency department visits and hospitalizations","volume":"16","author":"Kidwell","year":"2021","journal-title":"PLoS One"},{"key":"2025123106454429000_15.8.e104303.49","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00277-025-06216-1","article-title":"A review on disease modifying pharmacologic therapies for sickle cell disease","volume":"104","author":"Mahadevia","year":"2025","journal-title":"Ann Hematol"},{"key":"2025123106454429000_15.8.e104303.50","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24587"},{"key":"2025123106454429000_15.8.e104303.51","unstructured":"Dang JSDAK . Reducing Hospital Readmissions. StatPearls: StatPearls Publishing, 2024."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-104303","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T14:46:35Z","timestamp":1767192395000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-104303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":51,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,8]]},"published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1136\/bmjopen-2025-104303"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-104303","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]}}}